Portolan Capital Management, LLC Biolife Solutions Inc Transaction History
Portolan Capital Management, LLC
- $1.26 Billion
- Q3 2024
A detailed history of Portolan Capital Management, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Portolan Capital Management, LLC holds 427,876 shares of BLFS stock, worth $11.3 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
427,876
Previous 1,004,228
57.39%
Holding current value
$11.3 Million
Previous $21.5 Million
50.24%
% of portfolio
0.85%
Previous 1.9%
Shares
4 transactions
Others Institutions Holding BLFS
# of Institutions
198Shares Held
44.9MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$231 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$145 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$84.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$75.5 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$41.8 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.13B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...